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Abstract
Bats are increasingly being recognized as important reservoir hosts for a large number of viruses, some of them can be
highly virulent when they infect human and livestock animals. Among the new bat zoonotic viruses discovered in recent
years, several reoviruses (respiratory enteric orphan viruses) were found to be able to cause acute respiratory infections in
humans, which included Melaka and Kampar viruses discovered in Malaysia, all of them belong to the genus Orthoreovirus,
family Reoviridae. In this report, we describe the isolation of a highly related virus from an adult patient who suffered acute
respiratory illness in Malaysia. Although there was no direct evidence of bat origin, epidemiological study indicated the
potential exposure of the patient to bats before the onset of disease. The current study further demonstrates that spillover
events of different strains of related orthoreoviruses from bats to humans are occurring on a regular basis, which calls for
more intensive and systematic surveillances to fully assess the true public health impact of these newly discovered bat-
borne zoonotic reoviruses.
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Introduction
Up-to-date, approximately 1400 pathogen species are recog-
nized to infect humans. Although fewer than 200 of these are
viruses, on average, more than two new species of viruses infecting
humans are reported worldwide every year and novel viruses,
especially RNA viruses, are more likely to cause future emerging
infections [1]. Emerging novel viruses pose a major public health
concern, whether causing massive progressive pandemic disease
such as human immunodeficiency viruses or more transient events
such as the Nipah virus in 1998/1999 and SARS coronavirus in
2002/2003 [2,3,4].
Acute respiratory infections constitute the most common and
widespread human infectious diseases, especially amongst patients
seen at the outpatient clinics. Despite the application of various
diagnostic tests, the aetiological agents of a substantial proportion
of acute respiratory illnesses are still not known. Novel viruses with
the ability to cause respiratory infections and spread via the
respiratory route, such as the SARS coronavirus and pandemic
influenza A (H1N1), are of particular public health interest
because of their pandemic potential and their ability of rapid
spread via aerosol or droplet. The recent isolations of several novel
zoonotic orthoreoviruses from humans with acute respiratory
illness and the demonstration of their human-to-human transmis-
sion highlights the potential of emergence of a pandemic strain via
mutation and/or re-assortment of their segmented double-
stranded RNA genomes [5,6,7].
Viruses belonging to the family Reoviridae are a large and diverse
group of non-enveloped viruses with segmented double-stranded
RNA genomes [8]. The viruses within this family are taxonom-
ically classified into 12 genera in part depending on the number of
their dsRNA genomes. Members of the genus Orthoreovirus contain
10 genome segments and have been isolated from a broad range of
mammals, birds and reptiles. Viruses under this genus are divided
into two phenotypic groups, fusogenic and non-fusogenic, based
on the ability of the virus to cause cell-cell fusion and formation of
giant syncytial cells [9,10]. The mammalian orthoreoviruses
(MRV) are non-fusogenic whereas the remaining members of
the genus are fusogenic, including avian orthoreoviruses (ARV),
baboon orthoreoviruses (BRV), reptilian orhtoreoviruses (RRV)
and orthoreoviruses isolated from bats [11,12]. MRV infection in
humans has been shown to be fairly common and the infections
are often shown to be asymptomatic or associated with mild, self-
limiting respiratory or gastrointestinal illness in infants and
children [9]. However, infections associated with fusogenic
orthoreoviruses have been shown to be of serious consequences
ranging from neurological illness in baboon and snakes to
pneumonia and death in chickens [9].
Since 2006, two fusogenic orthoreoviruses, Melaka virus and
Kampar virus, have been independently isolated in Malaysia from
respiratory samples of patients with acute respiratory illness
though no death has been reported [5,6]. A similar virus was
discovered in Hong Kong from a patient who visited Bali a few
days before the onset of the severe respiratory illness [7]. All of
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to the Nelson Bay virus and Pulau virus, both of bat origin [11,13].
Due to the high genetic similarity of genome sequences and strong
cross reactivity at the serological level [6], it has been proposed,
after recent consultation with the International Committee on
Virus Taxonomy, that all of these viruses be placed under a new
species, Pteropine orthoreovirus (PRV), replacing the existing species,
Nelson Bay orthoreovirus. The new name has a better fit with other
existing species names in the genus such as Avian orthoreovirus (ARV)
and Mammalian orthoreovirus (MRV).
Epidemiological investigation by screening of sera collected
from human volunteers on the Pulau Island in Malaysia revealed
that 14 of 109 (13%) were positive for Pular virus, indicating that
this group of viruses may be able to switch host and infect humans
more frequently than other bat-borne viruses, such as the Nipah
virus [5]. Here, we describe the isolation and characterization of
another new PRV strain, the Sikamat strain, which represents the
seventh member in this species group (Table 1). This is the 4
th
isolate from human patients within a four-year period in the
absence of a targeted surveillance program. It can be predicted
that more human cases will be detected if systematic surveillance is
put in place for nations where fruit bats are present in significant
numbers.
Materials and Methods
Collection of clinical samples as part of the influenza
surveillance program
The investigation conducted in this study was approved by the
ethics committee of the Malaysian National Public Health
Laboratory. All patients (subjects) in this manuscript have given
written informed consent (as outlined in the PLoS consent form) to
publication of their case details. No identification of the subjects is
to be revealed in any publication.
A nation-wide influenza surveillance program in Malaysia was
initiated in 2004 under the national influenza pandemic prepared-
ness plan. As a requirement, attending doctors from two respective
designated government polyclinics per state were instructed to
collect throat swab specimens from patients with influenza-like
illnesses. Simultaneously, clinical and epidemiological information
of the patients were recorded in a standardized questionnaire and
sent together with the clinical specimens to the national public
health laboratory for influenza virus isolation and identification.
Virus isolation and preliminary identification
For virus isolation, throat swab samples in virus transport
medium (VTM) were gently vortexed after the addition of
crystalline penicillin (500 I.U.), streptomycin (200 mg) and
amphoteracin (50 mg). After incubation for an hour at room
temperature, the solution was inoculated in duplicates (100 ml and
200 ml, respectively) onto monolayer of MDCK (ATCC, CCL-34),
Vero (ATCC, CCL-81) and Hep-2 (ATCC, CCL-23) cells freshly
cultured in JM cell culture tubes [14]. The tubes were incubated at
37uC in an ambient of 5% CO2 and examined daily for evidence
of any cytopathic effect (CPE). For those samples showing CPE, a
0.5 ml-aliquot of the culture supernatant containing suspended
infected cells was carefully harvested and placed in a microfuge
tube. The infected cells were pelleted and washed twice with sterile
phosphate buffered saline (PBS) by centrifugation at 1000 g for
10 minutes. After the last wash, the infected cells were resus-
pended in 200 ml of sterile PBS and 10 ml of the suspension cells
were carefully layered onto each well of a 12-well Teflon coated
slide (Cel-Line/Erie Scientific Co., USA). The slide was allowed to
dry over a warm plate (42uC) placed in a BSC-II cabinet. The slide
was fixed for 10 minutes in cold acetone as soon as it was dried.
Initial identification of virus was made by indirect immunofluo-
rescence test using a panel of commercial monoclonal antibodies
for identification of respiratory viruses commonly known to infect
humans (Chemicon Inc., USA).
Serological study
Virus infected cells fixed in wells of Teflon coated slides were
used for serological investigation. Briefly, a fully confluent
monolayer of MDCK cells in a 25-cm
2 tissue culture flask was
washed twice with 5 ml of sterile PBS and treated with 2 ml of
0.25% trypsin containing 0.1% EDTA (HyClone Laboratories
Inc., Utah, USA). The MDCK cells were then suspended in 20 ml
of DMEM culture medium containing 10% fetal calf serum. A 5-
ml aliquot of the cell suspension was transferred into each of 4 new
25-cm
2 flasks and incubated at 37uC in an ambient of 5% CO2.
Once the cells reached confluent growth, the flasks were treated as
above. The suspended cells in each flask were inoculated with 10
7
TCID50 of each of the four viruses included in this study. At
24 hours post-inoculation, the infected cells (with full CPE) in the
suspension were harvested and washed 5 times with sterile PBS by
centrifugation at 1000 g for 10 minutes in each wash. A 25-cm
2
flask of suspended mock-infected MDCK cells was processed
exactly the same way as a negative control. After the last wash, the
mock-infected cells were distributed and added into the respective
infected cells in the ratio of 1:4. The volume of the mixed cell
suspension was adjusted with sterile PBS to a cell concentration of
approximately 1000 cells per 10 ml and subsequently 10 ml of the
final cell suspension was transferred into each well of the Teflon
coated slides. The slides were allowed to air dry in a BSL-2
cabinet, irradiated by UV-light and fixed in cold acetone for later
use.
Human sera were tested for the presence of virus-specific IgM
and IgG antibodies by indirect immunofluorecence assay using the
fixed infected cells prepared above. Convalescent human serum
samples were serially diluted from 1:20 to 1:2560 with sterile PBS.
Twenty microlitres of the diluted sera was used for immuno
staining as previously described [15]. The end point titre of
positive assay was taken as the highest serum dilution that gave at
least five cells with positive immunofluorescence.
Cross neutralization activity of convalescent human sera was
tested using a micro-neutralization test against 100 TCID50 of
each of the four viruses using a previously published method [5].
Molecular and sequence analysis
Extraction and purification of dsRNA, and genome segment
analysis were carried our as previously described by our group
Table 1. List of known strains of Pteropine orthoreovirus (PRV).
Strain Abbreviation Isolation details References
Year Host Location
Nelson Bay PRV1NB 1970 Bat Australia [11]
Pulau PRV2P 1999 Bat Malaysia [13]
Melaka PRV3M 2006 Human Malaysia [5]
Kampar PRV4K 2006 Human Malaysia [6]
HK23629/07 PRV5HK 2007 Human Hong Kong [7]
Xi River PRV6XR 2010 Bat China [17]
Sikamat PRV7S 2010 Human Malaysia This work
doi:10.1371/journal.pone.0025434.t001
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PCR with primers designed from conserved regions of known
viruses of the PRV species group. To obtain the sequence of
genome terminal ends, a seminested PCR was employed using a
combination of genome-specific primers and the primer comple-
mentary to the adaptor ligated to the genome ends [6]. All regions
of the genome segments were sequenced at least three times.
Phylogenetic analysis was conducted using MEGA4 [16].
Neighbour-Joining trees were constructed with bootstrap values
determined by 1000 replicates. Complete genome sequences of the
four S- class genome segments were deposited in GenBank under
accession numbers JF811580-3.
Results
Clinical presentations of the patient
A 46-year old policeman developed a sudden onset of high fever
with a sore throat and prostrating myalgia on 6 March 2010. The
fever was associated with severe anteriorly throbbing headache
and mild photophobia, but without blurring of vision. There was
no neck stiffness, abnormal muscle movement, seizure or loss of
consciousness. The myalgia was described as generalized and
associated with generalized body weakness, lethargy, malaise and
loss of appetite. His sore-throat was described as severe in nature
which was aggravated by swallowing of both solid and liquid food.
The sore-throat was associated with hoarseness of voice and nasal
blockage. There was no associated nasal discharge, cough or
breathing difficulty. On the following day, he developed moderate
abdominal pain over the epigastrium, but not associated with
vomiting or diarrhoea. There was no history of skin rashes or a
tendency to bleed. His illness was not relieved with self-medication
of anti-pyretics.
He received medical treatment at a government health clinic on
8 March 2010. At the outpatient clinic, he was noted to be febrile
(an axillary temperature of 39.8uC), ill-looking with mild
erythematous flushing over his face and chest that blanched on
pressure. He was noted to have mild conjunctivitis, but there was
no jaundice or petechiae spots noted. His tonsils were enlarged
and injected, but there was no white exudates noted over the oral
pharynx. He was not in any respiratory distress and his lungs were
clear with good bilateral air-entry on auscultation. Other systemic
examinations were essentially normal and there was no significant
enlarged lymph node noted. A provisional diagnosis of influenza-
like illness was made. A throat swab was collected in viral transport
medium and sent to the laboratory for virology investigation. He
was given erythromycin and a higher dose of anti-pyretic. On
follow-up on 12 March 2010, he still felt weak and lethargic with
mild myalgia and poor appetite though his fever had resolved on
11 March 2010.
The patient had no past significant severe illness that needed
hospitalization, neither was he on regular medication for any
chronic illness. There was no history of recent travel overseas or
into caves or jungles. There was no history of direct contact or
handling of any domestic or wild animal or contact with
neighbours or friends having similar illness. None of his other
family members, living in the same household, developed similar
illness within the month following his illness.
Epidemiological findings
The patient and his family live in a double storey-linked house
in Sikamat, a small town within the state of Negeri Sembilan, in
the central western region of peninsular Malaysia. There is no fruit
tree in the immediate surroundings of the house. However, for the
past two years, the patient and his wife have regularly returned to
stay over the weekend in their village house and were at the house
on the weekends before the onset of his disease. The village house
is situated in a 2-hectare orchard about 20 kilometres away from
his main residence and is surrounded with various types of tropical
fruit trees. Fruit bats are known to fly around in his orchard at
night and at times were known to fly into the house, but none were
found roosting inside the house. He has not directly handled any
bats or killed any of them. He and his wife did not consume any
fruit partially eaten by animal or insect or those drop on the
ground. The patient has 6 children, two sons and four daughters.
His two older sons, aged 22 and 20, occasionally assist him in the
orchard during the weekend, but did not stay overnight in the
village house. Samples of venous blood were collected from his
wife, one son (2
nd child) and two daughters (5
th and 6
th child) on 20
April 2010 and the status of their anti-PRV7S antibodies is shown
in Table 2. The patient’s wife and 2
nd son had IgM and IgG
antibodies to PRV7S though none of them had ever experienced
any febrile illness within a month of the onset of the patient’s
clinical symptoms.
Laboratory findings
The throat swab sample from the patient in viral transport
medium was processed for virus isolation as described in the
method section. After 3 days of incubation, syncytium-forming
CPE was noted in MDCK, but not in Hep-2 or Vero cells. After 2
passages in MDCK cells, the virus was able to replicate and cause
similar CPE in all types of mammalian cell lines available in the
laboratory (see SI Table 2 in reference [5]), including C6/36
(ATCC CRL-1660), a cell line of mosquito cell origin.
The infected MDCK cells failed to react with a commercial
monoclonal antibody panel used for identification of commonly
known respiratory viruses. On the other hand, the infected cells
reacted strongly with sera derived from patients infected with
PRV3M and PRV4K, respectively (data not shown). Further
cross-reactivity analyses indicated that convalescent sera from
patients infected with three different PRV strains all had high level
of cross reactivity (Figure 1, Table 3). This was further confirmed
by micro-neutralization assay (Table 3). It is worth noting that sera
from patients infected with each of the three different PRVs also
reacted with PRV2P, the only bat isolate of the PRV species group
obtained in Malaysia so far.
Molecular and phylogenetic characterization
Profiling of the genome segments for PRV7S on SDS-
polyacrylamide gel indicated that its electropherotype is similar
to those of other Malaysian PRVs, and is most closely related to
that of PRV3M (Figure 2). Analysis of both nucleotide and
deduced amino acid sequences for the four S- class segments of
Table 2. Titer of anti-PRV7S antibodies in the sera of the
patient and his family members.
Subjects Sampling date Serum antibody titer (dilution)
IgM IgG
Patient 2010-03-22 1 : 40 1 : 640
Patient’s wife 2010-04-10 1 : 20 1 : 320
Patient’s 2
nd son 2010-04-10 1 : 40 1 : 320
Patient’s 5
th daughter 2010-04-10 ,1:1 0 ,1:1 0
Patient’s 6
th daughter 2010-04-10 ,1:1 0 ,1:1 0
doi:10.1371/journal.pone.0025434.t002
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of the PRV species group (Table 4). PRV7S can be confidently
classified as a member of this species group based on the following
molecular characteristics: (i) The deduced protein products
encoded by the S- class genome segments of PRV7S are similar
in size and share high level of sequence identity with all known
members of the PRV species group (Table 4), including PRV6XR
that was recently isolated from Rousettus bats in China [17]; (ii)
The S1 genome segment of PRV7S is polycistronic and has
identical coding arrangement for p10, p17 and sC proteins as
seen in all members of the PRV species group, but different from
other orthoreoviruses; (iii) The 59 terminal consensus sequence is
GCUUUA, which is identical for PRV species group members,
but different from the other members of the genus Orthoreovirus.
Phylogenetic trees based on all four S-class genome segments
further confirmed that PRT7S is a member of the PRV species
group (Figure 3).
Discussion
The isolation of yet another orthoreovirus from a patient
suffering acute respiratory disease in Malaysia confirms the trend
of regular human infection by members of the Pteropine orthoreovirus
(PRV) species group. Considering that the detection of such events
was ‘‘accidental’’ in the sense that no targeted surveillance was
conducted, it can be predicted that the real frequency of spillover
will be higher.
To date, there are four confirmed outbreaks of human
respiratory illness caused by this group of viruses, three in
Malaysia and one in Bali/Hong Kong [5,6,7]. Although these
viruses are genetically and serologically related, it is evident from
the data presented in this and previous studies that each outbreak
was caused by a different strain or isolate, some more closely
related than others. Although there is a lack of direct evidence to
prove a bat-to-human transmission, epidemiological studies
indicated that patients from all four independent outbreaks had
Table 3. Antibody titer in patients’ convalescent serum
samples against each of the four PRV strains isolated in
Malaysia.
Strain
Antibody titer in human convalescent sera
IgG titer/neutralizing titer*
a-PRV3M
(day 32)
#
a-PRV4K
(day 32)
a-PRV7S
(day 16)
PRV2P 1:320/1:160 1:320/1:40 1:160/1:80
PRV3M 1:2560/1:1280 1:640/1:60 1:320/1:160
PRV4K 1:640/1:160 1:1280/1:640 1:320/1:160
PRV7S 1:640/1:320 1:640/1:160 1:640/1:320
*IgG titer was determined by immunofluorescence antibody test using fixed
MDCK cells infected with each of the four viruses; neutralizing titer was
determined using the micro-neutralization test with 100 TCID50 for each of the
four viruses.
#Sampling time, expressed as days after onset of symptoms, is indicated for
each serum.
doi:10.1371/journal.pone.0025434.t003
Figure 2. Comparison of genome segment profiles between
PRV3M and PRV7S. The genome segments were separated in a 10%
SDS-polyarylamide gel. The classes of genome segments (L, M and S)
are labeled on the right. The asterisk (*) indicates co-migrating bands
and the open arrow (.) indicates cognate segments of the two viruses
with a different mobility.
doi:10.1371/journal.pone.0025434.g002
Figure 1. Immunofluorescence staining of four PRVs using
human patient sera. MDCK cells infected with PRV3M, PRV4K, PRV2P
and PRV7S (presented in panels from top to bottom), respectively, were
each probed with convalescent serum from patient infected with
PRV3M, PRV4K and PRV7S (from left to right), respectively. All human
sera were used at 1:40 dilution.
doi:10.1371/journal.pone.0025434.g001
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[5,6,7]. The most direct evidence came from the human infection
by PRV3M, in which the patients’ house was visited by a bat
approximately a week prior to the onset of clinical disease in the
index patient, followed by 3 additional human infections in the
same family [5].
While there is the possibility of PRV infection in other wildlife
animal(s), it is clear that bats are at least one of the natural
reservoir hosts based on the fact that closely related PRVs have
been isolated from three different bat species in three well
separated geographic locations in Australia, Malaysia and China
[11,13,17]. Based on phylogenetic analysis carried out for all of the
Table 4. Comparison of sequence identity and size (aa residues) of PRV7S S-encoded proteins to those of PRV6XR, PRV5HK, PRV4K,
PRV3M, PRV2P and PRV1NB.
PRV7S segment/protein (size in aa residues) Percentage sequence identity to cognate PRV7S protein (size in aa residues)
PRV6XR PRV5HK PRV4K PRV3M PRV2P PRV1NB
S1/p10 (95) 71% (95) 91% (89) 94% (95) 99% (95) 98% (95) 70% (95)
S1/p17 (142) 56% (147) 87% (142) 85% (142) 98% (142) 92% (142) 52% (140)
S1/sC (332) 48% (323) 66% (324) 56% (331) 97% (328) 80% (327) 42% (323)
S2/s1 (416) NA* 93% (391) 99% (416) 99% (416) 98% (416) 97% (416)
S3/sNS (367) 99% (367) 94% (347) 99% (367) 99% (367) 99% (367) 98% (367)
S4/s2 (416) NA* 97% (357) 97% (361) 99% (361) 94% (361) 94% (361)
*NA: sequence not available.
doi:10.1371/journal.pone.0025434.t004
Figure 3. Phylogenetic trees based on the nucleotide sequence of the four S-class genome segments of orthoreoviruses.
Abbreviations: ARV, Avian orthoreovirus; BRV, baboon orthoreovirus; DRV, Muscovy duck reovirus; MRV; Mammalian orthoreovirus. See Table 1 for
the abbreviations of all seven Pteropine orthoreovirus strains known to date. The percentage of replicate trees in the bootstrap test (1000 replicates)
is shown next to the branching node.
doi:10.1371/journal.pone.0025434.g003
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are a number of diverse viruses circulating among different bat
populations, and similar viruses are capable of infecting bats from
a different genetic background. As shown in Figure 3, among the
three strains isolated from bats, PRV1NB (isolated from Pteropus
poliocephalus in Australia), PRV2P (isolated from Pteropus hypomelanus
in Malaysia) and PRV6XR (isolated from Rousettus leschenaultia in
China), PRV1NB was clustered closer to PRV6XR than to
PRV2P despite the fact that PRV1NB and PRV2P were isolated
from bats in the same genus, Pteropus, while PRV6XR was from
the genus Rousettus. The viral genetic diversity is also reflected by
the four viruses isolated from human patients. Although they are
closely related, they represented four independent spillover events
associated with four distinctive viruses.
It is important to emphasize that among all three outbreaks
investigated in Malaysia so far, each was associated with multiple
human infections. Although one cannot exclude the possibility that
this could be a result of independent bat-to-human transmission,
epidemiological tracing suggested they were more likely the result
of human-to-human transmission [5,6]. This is also true for the
cases presented in this study. In this context, it is important to note
that among the multiple infections during each outbreak, there
was at least one asymptomatic human infection [5,6]. It is
therefore possible that the first human case detected (the index
case) may not be the first case of infection following spillover from
a reservoir host.
In summary, recent studies demonstrated that there are a large
number of genetically diverse PRVs circulating among different
bats in geographically separated locations. Many, if not all of
them, have the potential to infect human and cause respiratory
disease outbreaks. These viruses can be transmitted between
humans and the resulting clinical presentations vary with different
individuals, from symptomless to severe respiratory illness or
diarrhoea [5,6,7]. To date, there is no evidence of virus persistence
among infected human populations. However, considering the
great virus diversity in bats and asymptomatic infection in humans,
it is possible for this group of viruses to adapt to become a
common respiratory pathogen of humans.
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